IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
30.00
+1.40 (4.90%)
Nov 4, 2024, 4:00 PM EST - Market closed
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for IDEAYA Biosciences stock have an average target of 55.45, with a low estimate of 44 and a high estimate of 68. The average target predicts an increase of 84.83% from the current stock price of 30.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IDYA stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 6 |
| Buy | 5 | 5 | 6 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 11 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $53 | Buy | Reiterates | $53 | +76.67% | Oct 29, 2024 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +66.67% | Oct 24, 2024 |
| Wedbush | Wedbush | Buy Maintains $54 → $52 | Buy | Maintains | $54 → $52 | +73.33% | Sep 24, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $61 | Buy | Reiterates | $61 | +103.33% | Sep 24, 2024 |
| Stifel | Stifel | Strong Buy Maintains $63 → $68 | Strong Buy | Maintains | $63 → $68 | +126.67% | Sep 10, 2024 |
Financial Forecast
Revenue This Year
9.54M
from 23.39M
Decreased by -59.20%
Revenue Next Year
17.99M
from 9.54M
Increased by 88.53%
EPS This Year
-2.50
from -1.96
EPS Next Year
-2.83
from -2.50
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.3M | 67.9M | 264.7M | ||
| Avg | 9.5M | 18.0M | 68.9M | ||
| Low | n/a | n/a | 14.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.3% | 611.8% | 1,371.4% | ||
| Avg | -59.2% | 88.5% | 283.0% | ||
| Low | - | - | -17.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.86 | -2.28 | -1.00 | ||
| Avg | -2.50 | -2.83 | -2.61 | ||
| Low | -2.75 | -3.42 | -3.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.